<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02869737</url>
  </required_header>
  <id_info>
    <org_study_id>CECIC 2015-03</org_study_id>
    <nct_id>NCT02869737</nct_id>
  </id_info>
  <brief_title>Utility of Point-of-care Device for Rapid Determination of Cogulopathy in Trauma Patients</brief_title>
  <acronym>Coaguchek</acronym>
  <official_title>Utility of Point-of-care Device for Rapid Determination of Cogulopathy in Trauma Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Traumatic coagulopathy is frequent and is an independent risk factor of mortality. Its
      detection mainly relies upon classic biological test like the prothrombin time and the
      international normaliezd ratio (INR). These tests are not available at the bedside. Point of
      care (POC) device for INR measurement are now available like the Coaguchek, Roche, France.
      The aim of the present study is to test the correlation between the POC INR and the
      laboratory INR.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Concordance between POC INR and laboratory INR using 3 classes: normal &lt; 1.1, moderate : 1.1-1.5, severe: &gt;1.5</measure>
    <time_frame>Admission</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prediction of RBC transfusion</measure>
    <time_frame>24 hours post admission</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prediction of FFP transfusion</measure>
    <time_frame>24 hours post admission</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-hospital mortality assessed using patients' files</measure>
    <time_frame>up to Day 28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Injury severity (ISS)</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Organ failure measured with the SOFA score at Day 1</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">100</enrollment>
  <condition>Severe Trauma</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Coagucheck, Roche, France</intervention_name>
    <description>Capillary puncture for POC INR measurement</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admited for a suspicion of severe trauma wirth active bleeding in a level I trauma
        center
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 15 y-o

          -  Admission for severe trauma

        Exclusion Criteria:

          -  Patients under oral anticoagulant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 9, 2016</study_first_submitted>
  <study_first_submitted_qc>August 12, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 17, 2016</study_first_posted>
  <last_update_submitted>August 12, 2016</last_update_submitted>
  <last_update_submitted_qc>August 12, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Point of Care Device; post traumatic coagulopathy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

